Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Zimmer Biomet Holdings, Inc. (ZBH)

129.2   2.44 (1.92%) 03-31 16:03
Open: 127.92 Pre. Close: 126.76
High: 129.32 Low: 127.7
Volume: 1,212,585 Market Cap: 27,140(M)

Technical analysis

as of: 2023-03-31 4:23:24 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 151.04     One year: 176.42
Support: Support1: 124.16    Support2: 120.98
Resistance: Resistance1: 129.32    Resistance2: 151.04
Pivot: 126.07
Moving Average: MA(5): 126.95     MA(20): 125.33
MA(100): 123.64     MA(250): 117.16
MACD: MACD(12,26): 0.6     Signal(9): 0.2
Stochastic oscillator: %K(14,3): 82.6     %D(3): 74.5
RSI: RSI(14): 62.3
52-week: High: 135.05  Low: 100.38
Average Vol(K): 3-Month: 1,424 (K)  10-Days: 851 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ ZBH ] has closed It is unclear right now based on current values. 44.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 129.33 - 129.78 129.78 - 130.2
Low: 126.38 - 126.97 126.97 - 127.51
Close: 128.19 - 129.01 129.01 - 129.76

Company Description

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Headline News

Fri, 31 Mar 2023
Zimmer Biomet Holdings Inc. stock rises Friday, outperforms market - MarketWatch

Fri, 31 Mar 2023
Hartford Investment Management Co. Sells 4789 Shares of Zimmer ... - MarketBeat

Thu, 30 Mar 2023
Fitch Affirms Zimmer Biomet at 'BBB'; Outlook Stable - Fitch Ratings

Wed, 29 Mar 2023
Zimmer Biomet's ROSA HIP with ONE Planner Hip Awarded ... - PR Newswire

Thu, 23 Mar 2023
Guru Fundamental Report for ZBH - Nasdaq

Wed, 22 Mar 2023
Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 210 (M)
Shares Float 209 (M)
% Held by Insiders 0 (%)
% Held by Institutions 90.9 (%)
Shares Short 3,160 (K)
Shares Short P.Month 2,380 (K)

Stock Financials

EPS 1.37
EPS Est Next Qtl 2.26
EPS Est This Year 8.22
EPS Est Next Year 8.76
Book Value (p.s.) 57.5
Profit Margin (%) 3.3
Operating Margin (%) 19
Return on Assets (ttm) 3.7
Return on Equity (ttm) 2.3
Qtrly Rev. Growth 2.7
Gross Profit (p.s.) 23.42
Sales Per Share 33.03
EBITDA (p.s.) 10.71
Qtrly Earnings Growth 0
Operating Cash Flow 1,280 (M)
Levered Free Cash Flow 1,700 (M)

Stock Valuations

PE Ratio 94.24
PEG Ratio 3
Price to Book value 2.24
Price to Sales 3.9
Price to Cash Flow 21.18

Stock Dividends

Dividend 0.23
Forward Dividend 0
Dividend Yield 0.1%
Dividend Pay Date 2022-01-30
Ex-Dividend Date 2021-12-26
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.